top of page

16 January 2024: Pentagrit to present "Deep Phenotyping Zebrafish Models of ALS, Parkinson's, Tauopathy and Huntington's" at 2nd ACE DRUG DISCOVERY SUMMIT on 20th - 21st MARCH, 2024 at THE INSURANCE HALL LONDON, UK

08 November 2023:  Watch out for the release of our glucocerebrosidase deficient model with severe lysosomal storage disruption leading to toxic gain of function.

29 August 2023: Pentagrit launches a fool proof assay for ALS drug discovery candidates - Read more on " A Clinical Biomarker Assay for ALS Drug Screening in zebrafish model" at https://www.pentagrit.com/post/cortical-excitability-assay-in-als-model

04 August 2023: Learn more on new solutions for Rheumatoid Arthritis drug discovery and solutions in our model https://www.pentagrit.com/post/arthritis-drug-design-challenges-solutions-in-zebrafish-model

15 May 2023: Watch our presentation on comparison of windows of screening for Neurology Models in zebrafish. https://www.pentagrit.com/blog

06 April 2023:  "Endpoint Data" Watch out for our upcoming round up of ECG detected Cardiovascular Toxicity in zebrafish - https://www.pentagrit.com/zebrafishecg

04 April 2023: "Pentagrit Talks" Watch our discussions to identify new targets for NASH with Dr.Bibhas Kar at https://www.youtube.com/watch?v=VOftLDUKn_8

bottom of page